What Canopy Clinical Research does

Canopy Clinical Research is an Australian multi-site private clinical trials network founded in 2020, operating Phase I through Phase IV studies across vaccines, metabolic, cardiovascular, dermatology, respiratory, oncology, and other therapeutic areas. The company runs four operational sites in Brookvale (NSW), Miranda (NSW), Wollongong (NSW) and Altona North (VIC), with a newly opened Inner West site in Leichhardt (May 2026) and a Western Sydney site at Penrith in development. The network is equipped with GCP-compliant workflows, calibrated on-site equipment (ECG, spirometry, -80°C freezers, PC1 lab rooms), and is supported by a pre-screened participant database of 38,000+ individuals managed by a dedicated central recruitment and retention team.

The core product is site-based clinical trial services delivered to pharmaceutical sponsors, biotechnology companies, and CROs, augmented by two sub-brands: Canopy Cancer Care (oncology research, partnered with Cancer Care Associates) and Canopy Consulting (advisory for biotechs entering Australia). Technology infrastructure includes the Clinrol Connect patient engagement and recruitment platform, which applies AI-based patient prioritisation and integrates with Canopy's CTMS, alongside GP referral workflows compatible with Best Practice and Medical Director software.

Revenue is generated on a project basis from individual study contracts negotiated with sponsors and CROs (50+ sponsors and 15+ CRO partners named, including Novartis, Moderna, Novavax, GSK, Merck, Novo Nordisk, PPD, ICON, and Novotech). Pricing is not publicly disclosed and is negotiated per study. The go-to-market combines direct enterprise sales (CEO and Head of Business Development attend BIO, ADA, and GPCE conferences), a community-led GP/specialist referral network, event-driven awareness, and direct-to-consumer participant recruitment through digital channels and a Consumer Advisory Panel. The leadership team is drawn heavily from senior roles at global top-5 CROs and major pharmaceutical companies, which is the company's principal differentiating talent asset.

Name

Canopy Clinical Research

Legal name

Canopy Clinical Research

Website

https://canopycr.com.au

Company type

Private

Founded year

2020

Operating status

Operating

Short description

Canopy Clinical Research is an Australian multi-site private clinical trials network founded in 2020, conducting Phase I-IV studies for pharmaceutical, biotech, and CRO sponsors across multiple therapeutic areas including oncology, metabolic, and cardiovascular. It operates across NSW and Victoria with a 38,000+ pre-screened participant database.

Ownership category

akta.pro rank

Product category

Clinical Research Site Network Services

NAICS

Medical and Diagnostic Laboratories (6215), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industry

Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC)

Keywords

• Clinical trial services
• Patient recruitment
• Contract research site
• Oncology research
• Vaccine clinical studies

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Clinical Trial Services for Sponsors: Canopy Clinical conducts Phase I through Phase IV clinical trials on behalf of pharmaceutical, biotechnology companies, and CROs. Sponsors pay for site services including participant recruitment, study execution, data collection, and regulatory compliance. Revenue is project-based, tied to individual trial contracts with milestones.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels8 records

Core offering

Canopy Clinical Research operates a multi-site private clinical trials network that conducts Phase I (non-confinement) through Phase IV trials for pharmaceutical, biotechnology, and CRO sponsors across Australia. It recruits participants through a 38,000+ pre-screened database and delivers oncology (Canopy Cancer Care) and consulting (Canopy Consulting) services alongside its core site network.

Product overview

Canopy Clinical Research is a multi-site private clinical trials network operating as a unified platform with specialized sub-brands and services. The core offering consists of Phase I through Phase IV clinical trial services across six locations in Australia. Supporting the core clinical trials business are two key sub-brands: Canopy Cancer Care (oncology research services) and Canopy Consulting (strategic consulting for biotechs and sponsors). The company also offers individual clinical trials including studies in oncology (PEAK-1), metabolic/weight management (multiple programs), cardiovascular (hypertension, atherosclerosis), respiratory (asthma), dermatology (venous leg ulcers, toenail fungal infection), musculoskeletal (osteoarthritis, gout), diabetes, neurology (migraine, panic disorder), and gastroenterology (coeliac disease). The network's infrastructure includes the Clinrol patient recruitment technology platform for streamlined operations.

Differentiator

Problem solved

Functional benefit

Brands

• Canopy Consulting: Consulting service partnering with biotechs and sponsors considering Australia to run their clinical trials, offering CRO selection, regulatory navigation, and trial oversight support.
• Canopy Cancer Care

Products and services

• Canopy Clinical Research - Clinical Trial Services Multi-site private clinical trials network conducting Phase I (non-confinement) through Phase IV clinical trials for pharmaceutical, biotechnology, and CRO sponsors across therapeutic areas including vaccines, metabolic, cardiovascular, sexual health, dermatology, and mental health.
• Canopy Cancer Care Oncology research service focused on bringing leading global clinical trials closer to people living with cancer across Australia, partnering with cancer care networks, hospitals, and specialists.
• Canopy Consulting

Quantifiable outcome

• Met or exceeded recruitment targets on >90% of trials performed to date, and was the top recruiter for 80% of those trials
• +3 more outcomes

Named customers11 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability3 records

Feature2 records

Partnerships

Two partnerships are on record, tiered core.

• ClinrolcoreTechnology or Integration · 19 June 2026Canopy Clinical Research selected Clinrol as its preferred patient recruitment technology platform for select clinical trial studies across its five locations. Clinrol Connect serves as the recruitment layer across Canopy's operations, centralising patient engagement, pre-screening, communication and workflow management while integrating with their CTMS. Features include consolidating call handling, automating reminders and rescheduling, structured phone screening with live eligibility checks, and AI-based patient prioritisation. Implementation was conducted across live studies, allowing workflows to be tested in real-world conditions.
• Cancer Care AssociatescoreStrategic or Co-development PartnerPartnership focused on expanding access to high-quality oncology clinical trials and investigational therapies for people living with cancer, bringing research opportunities closer to home without the burden of travelling far from support networks. Canopy's oncology nursing team and Cancer Care Associates' specialist network collaborate on patient identification and trial delivery.

Scale indicators14 records

Recent moves9 records

Expansion highlights5 records

Others

• IQVIA: Global CRO with owned site network and site-management services in Australia; comparable to Canopy as both a CRO partner channel and a competitive site operator.

Direct peers

• Scientia Clinical Research: Sydney-based early-phase clinical trials unit, directly comparable to Canopy as a private Australian site running Phase I trials for global sponsors.
• CMAX Clinical Research: Adelaide-based independent clinical trial site, comparable to Canopy as an Australian-owned SMO serving international pharma sponsors across multiple therapeutic areas.
• Linear Clinical Research: Perth-based early-phase clinical trials unit, comparable to Canopy as an Australian site operator running Phase I trials for global pharma and biotech sponsors.
• Emeritus Research: Australian clinical trial site network focused on outpatient and investigator-led research, comparable in operating model to Canopy's multi-therapeutic site network.
• Nucleus Network: Australian clinical trial site network specialising in early-phase (Phase I) healthy volunteer and patient studies, directly comparable to Canopy's Phase I–IV site operations in Australia.
• Novotech: APAC-focused CRO headquartered in Australia with extensive site management and clinical operations across the region; comparable to Canopy as both a CRO partner and a competitor for Australia-based trial execution.

Broad incumbents

• ICON plc: Global top-5 CRO with significant site operations in Australia; directly comparable as a buyer of trial site services, and as a competitor when sponsors prefer integrated CRO+site solutions.
• Parexel: Global CRO with established Australia presence and strong biotech sponsor relationships, comparable to Canopy as a clinical development partner for sponsors entering Australia.

Emerging players

• Velocity Clinical Research: US-headquartered integrated site network rapidly expanding internationally; comparable to Canopy in being a multi-site SMO serving large pharma, though at materially greater scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/CanopyClinicalResearch
• LinkedInlinkedin.com/company/canopyclinicalresearch
• Instagraminstagram.com/canopy.clinical

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Canopy Clinical Research